The social context of cardiovascular disease: challenges and opportunities for the Jackson Heart Study

David R Williams1, Jacinta Leavell

  • 1Department of Society, Human Development and Health, Harvard School of Public Health, Boston, MA 02115, USA. dwilliam@hsph.harvard.edu

Ethnicity & Disease
|November 20, 2012
PubMed

Insights

Cardiovascular disease (CVD) disparities between African Americans and Whites are increasing, with earlier onset and greater severity in Black individuals. Further research is crucial to understand and address these widening racial gaps in heart health.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • African Americans experience disproportionately higher rates of cardiovascular disease (CVD) compared to White populations.
  • This racial disparity in heart disease is not only prevalent but also widening over time.
  • Significant differences in CVD onset, severity, and outcomes exist even when controlling for socioeconomic status.

Purpose of the Study:

  • To identify critical research opportunities for the Jackson Heart Study.
  • To advance the scientific understanding of racial disparities in CVD.
  • To inform effective strategies for addressing these health inequities.

Main Methods:

  • The paper proposes a multi-faceted research agenda.
  • Key areas include a life course perspective, social stressors, and racism's impact.
  • Further investigation into risk factors, genetics, resilience, and economic influences is recommended.

Main Results:

  • The study highlights the complex interplay of factors contributing to CVD racial disparities.
  • Identified research opportunities aim to deepen the understanding of these contributing factors.
  • The findings underscore the need for targeted interventions and continued research.

Conclusions:

  • Addressing the widening racial gap in cardiovascular disease requires a comprehensive research approach.
  • Future research should integrate life course, social, genetic, and economic factors.
  • The Jackson Heart Study is positioned to make significant contributions to reducing CVD disparities.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...